Loading...
MET and VEGF: synergistic targets in castration-resistant prostate cancer
Recent advances in the treatment of prostate cancer have resulted in improved outcomes, including longer survival, but new options are needed for treating patients with castration-resistant disease, particularly in the presence of bone metastasis. Data from preclinical models and clinical biomarker...
Na minha lista:
| Udgivet i: | Clin Transl Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4422050/ https://ncbi.nlm.nih.gov/pubmed/21975330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-011-0719-5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|